FDA Announces Joint Meeting of Psychopharmacologic Drugs Advisory Committee and Pediatric Advisory Committee

Summary

The US Food and Drug Administration (FDA) has scheduled a joint meeting of its Psychopharmacologic Drugs Advisory Committee and Pediatric Advisory Committee to discuss various pharmaceutical proposals, with the meeting set to take place on March 15, 2023, at the FDA's White Oak Campus in Silver Spring, Maryland.